Ha habido 50 transacciones internas recientes registradas para AtriCure, Inc. (ATRC), incluyendo 19 compras y 25 ventas. El total de compras internas fue valorado en $106.21K y el total de ventas internas en $6.58M.
Internos destacados con actividad reciente incluyen Doraiswamy Vinayak, White Robert S., Carrel Michael H. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — ATRC
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-12 |
Doraiswamy Vinayak |
Chief Scientific Officer |
Venta Informativa |
5,000 |
$29.83 |
$149.15K |
96,875 |
| 2026-03-10 |
White Robert S. |
Director |
Ejercicio de Opciones (Venta) |
10,000 |
$14.99 |
$149.9K |
- |
| 2026-03-06 |
Carrel Michael H |
President, CEO, & Director |
Donación (Otorgada) |
1,000 |
- |
- |
778,498 |
| 2026-03-01 |
Carrel Michael H |
President, CEO, & Director |
Concesión de RSU |
68,618 |
- |
- |
755,995 |
| 2026-03-01 |
Privitera Salvatore |
Chief Technical Officer |
Concesión de RSU |
30,390 |
- |
- |
155,977 |
| 2026-03-01 |
Seith Douglas J |
Chief Operating Officer |
Concesión de RSU |
42,386 |
- |
- |
226,756 |
| 2026-03-01 |
Noznesky Justin J |
Chief Mktg & Strategy Officer |
Retención Fiscal de RSU |
15,586 |
$31.26 |
$487.22K |
106,401 |
| 2026-03-01 |
Wirick Angela L |
Chief Financial Officer |
Concesión de RSU |
39,987 |
- |
- |
204,757 |
| 2026-03-01 |
Dahlquist Karl S. |
Chief Legal Officer |
Retención Fiscal de RSU |
15,687 |
$31.26 |
$490.38K |
96,053 |
| 2026-03-01 |
Doraiswamy Vinayak |
Chief Scientific Officer |
Retención Fiscal de RSU |
15,585 |
$31.26 |
$487.19K |
101,875 |
| 2025-12-31 |
Seith Douglas J |
Chief Operating Officer |
Concesión de RSU |
257 |
$27.37 |
$7.03K |
184,370 |
| 2025-12-10 |
Carrel Michael H |
President, CEO, & Director |
Donación (Otorgada) |
4,000 |
- |
- |
687,377 |
| 2025-11-26 |
Noznesky Justin J |
Chief Mktg & Strategy Officer |
Venta Informativa |
5,166 |
$37.29 |
$192.64K |
78,798 |
| 2025-11-25 |
Wehrwein Sven |
Director |
Ejercicio de Opciones (Venta) |
4,967 |
$19.95 |
$99.09K |
25,000 |
| 2025-11-24 |
Wehrwein Sven |
Director |
Ejercicio de Opciones (Venta) |
5,033 |
$19.95 |
$100.41K |
29,967 |
| 2025-11-21 |
Yuen Maggie |
Director |
Venta Informativa |
3,000 |
$35.72 |
$107.16K |
11,371 |
| 2025-11-13 |
Carrel Michael H |
President, CEO, & Director |
Donación (Otorgada) |
6,000 |
- |
- |
691,377 |
| 2025-09-12 |
Noznesky Justin J |
Chief Mktg & Strategy Officer |
Venta Informativa |
3,000 |
$36.30 |
$108.9K |
83,964 |
| 2025-08-22 |
Wehrwein Sven |
Director |
Venta Informativa |
5,000 |
$37.00 |
$185K |
34,374 |
| 2025-08-19 |
Wehrwein Sven |
Director |
Venta Informativa |
5,000 |
$36.00 |
$180K |
34,374 |
| 2025-08-08 |
Carrel Michael H |
President, CEO, & Director |
Donación (Otorgada) |
10,000 |
- |
- |
697,377 |
| 2025-08-06 |
Groves Regina E |
Director |
Venta Informativa |
2,452 |
$36.82 |
$90.28K |
33,715 |
| 2025-08-05 |
Doraiswamy Vinayak |
Chief Scientific Officer |
Venta Informativa |
2,500 |
$36.58 |
$91.45K |
71,872 |
| 2025-06-30 |
Carrel Michael H |
President, CEO, & Director |
Concesión de RSU |
822 |
$25.84 |
$21.24K |
707,377 |
| 2025-06-30 |
Privitera Salvatore |
Chief Technical Officer |
Concesión de RSU |
822 |
$25.84 |
$21.24K |
125,587 |
| 2025-06-30 |
Seith Douglas J |
Chief Operating Officer |
Concesión de RSU |
550 |
$25.84 |
$14.21K |
184,113 |
| 2025-06-30 |
Dahlquist Karl S. |
Chief Legal Officer |
Concesión de RSU |
822 |
$25.84 |
$21.24K |
68,551 |
| 2025-06-30 |
Doraiswamy Vinayak |
Chief Scientific Officer |
Concesión de RSU |
822 |
$25.84 |
$21.24K |
74,372 |
| 2025-05-28 |
Doraiswamy Vinayak |
Chief Scientific Officer |
Venta Informativa |
2,500 |
$33.44 |
$83.6K |
73,550 |
| 2025-05-19 |
Wehrwein Sven |
Director |
Concesión de RSU |
5,401 |
- |
- |
34,374 |
| 2025-05-19 |
Johnson B Kristine |
Director |
Concesión de RSU |
5,401 |
- |
- |
49,810 |
| 2025-05-19 |
Prange Karen |
Director |
Concesión de RSU |
5,401 |
- |
- |
23,229 |
| 2025-05-19 |
White Robert S. |
Director |
Concesión de RSU |
5,401 |
- |
- |
112,174 |
| 2025-05-19 |
Groves Regina E |
Director |
Concesión de RSU |
5,401 |
- |
- |
36,167 |
| 2025-05-19 |
Yuen Maggie |
Director |
Concesión de RSU |
5,401 |
- |
- |
14,371 |
| 2025-05-19 |
Telman Deborah H |
Director |
Concesión de RSU |
5,401 |
- |
- |
22,184 |
| 2025-05-19 |
Nachman Shlomo |
Director |
Concesión de RSU |
5,401 |
- |
- |
18,511 |
| 2025-05-05 |
White Robert S. |
Director |
Ejercicio de Opciones (Venta) |
10,000 |
$22.62 |
$226.2K |
- |
| 2025-03-10 |
Carrel Michael H |
President, CEO, & Director |
Donación (Otorgada) |
4,000 |
- |
- |
706,555 |
| 2025-03-05 |
Prange Karen |
Director |
Venta Informativa |
6,100 |
$38.12 |
$232.53K |
17,828 |
| 2025-03-01 |
Carrel Michael H |
President, CEO, & Director |
Concesión de RSU |
50,335 |
- |
- |
703,574 |
| 2025-03-01 |
Privitera Salvatore |
Chief Technical Officer |
Retención Fiscal de RSU |
8,397 |
$38.74 |
$325.3K |
124,765 |
| 2025-03-01 |
Seith Douglas J |
Chief Operating Officer |
Retención Fiscal de RSU |
15,050 |
$38.74 |
$583.04K |
183,563 |
| 2025-03-01 |
Noznesky Justin J |
Chief Mktg & Strategy Officer |
Retención Fiscal de RSU |
9,673 |
$38.74 |
$374.73K |
86,964 |
| 2025-03-01 |
Wirick Angela L |
Chief Financial Officer |
Retención Fiscal de RSU |
13,633 |
$38.74 |
$528.14K |
164,770 |
| 2025-03-01 |
Dahlquist Karl S. |
Chief Legal Officer |
Retención Fiscal de RSU |
9,870 |
$38.74 |
$382.36K |
67,729 |
| 2025-03-01 |
Doraiswamy Vinayak |
Chief Scientific Officer |
Retención Fiscal de RSU |
9,672 |
$38.74 |
$374.69K |
76,050 |
| 2025-03-01 |
Yount Deborah Lee |
Chief Human Resources Officer |
Retención Fiscal de RSU |
11,961 |
$38.74 |
$463.37K |
45,578 |
| 2024-12-11 |
Noznesky Justin J |
Chief Mktg & Strategy Officer |
Donación (Otorgada) |
585 |
- |
- |
70,699 |
| 2024-08-15 |
Yuen Maggie |
Director |
Venta Informativa |
3,500 |
$24.07 |
$84.25K |
8,970 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
